These changes will almost certainly result in substantial enrollment declines, particularly among younger and healthier individuals, causing the Medicaid population to (once again) skew older and sicker, and likely worsening the utilization, acuity, and MLR challenges that health plans are already experiencing
Metformin addresses insulin resistance through hepatic glucose production inhibition, while semaglutide enhances insulin secretion and reduces appetitetwo distinct mechanisms targeting type 2 diabetes pathophysiology
Or adverse reactions with oral administration of LUXXE WHITE for prolonged use
That said, the clinical significance specifically in EDS populations is unknown no studies have directly examined these effects in connective tissue disorders
10.1016/j.rbmo.2016.06.006 40
Not only would the way of taking the drug be easier for most, but the company also said the drug would be cheaper to manufacture